Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9723687 | 1.00 | MAPT (0.53) | MAPTDGKALMNAKDM4EDUSP3 | |
| SCHEMBL28605449 | 1.00 | MAPT (0.53) | MAPTDGKALMNAKDM4EDUSP3 | |
| SCHEMBL28358120 | 1.00 | MAPT (0.53) | MAPTDGKALMNAKDM4EDUSP3 | |
| SCHEMBL28005808 | 1.00 | MAPT (0.53) | MAPTDGKALMNAKDM4EDUSP3 | |
| SCHEMBL20853447 | 1.00 | MAPT (0.53) | MAPTDGKALMNAKDM4EDUSP3 | |
| SCHEMBL4726015 | 1.00 | MAPT (0.53) | MAPTDGKALMNAKDM4EDUSP3 | |
| SCHEMBL28285143 | 0.98 | MAPT (0.51) | MAPTDGKALMNAKDM4EDUSP3 | |
| SCHEMBL27796633 | 0.91 | DGKA (0.57) | MAPTDGKALMNADUSP3 | |
| SCHEMBL9723690 | 0.88 | PAM (0.54) | MAPTDGKALMNAKDM4EDUSP3 | |
| SCHEMBL9220943 | 0.88 | PAM (0.54) | MAPTDGKALMNAKDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024134610-A2 | ARTIFICIAL PROTEIN COMPOSITIONS | FORMO BIO GMBH (DE) | 2024-06-27 | — | — | WO | claimed |
| EP-0686025-B1 | TITANIUM DIOXIDE DISPERSIONS, COSMETIC COMPOSITIONS AND METHODS FOR USING THE SAME | ESTEE LAUDER INC (US) | 2003-09-10 | — | — | EP | claimed |
| WO-2024134610-A2 | ARTIFICIAL PROTEIN COMPOSITIONS | FORMO BIO GMBH (DE) | 2024-06-27 | — | — | WO | disclosed |
| EP-3723503-B1 | PLANT-PROTEIN BASED TEXTURIZED OIL-IN-WATER EMULSIONS | NESTLE SA (CH) | 2024-03-20 | — | — | EP | disclosed |
| US-11653663-B2 | Plant-protein based texturized oil-in-water emulsions | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2023-05-23 | — | — | US | disclosed |
| US-20210177000-A1 | PLANT-PROTEIN BASED TEXTURIZED OIL-IN-WATER EMULSIONS | NESTEC S.A. (CH) | 2021-06-17 | — | — | US | disclosed |
| EP-3723503-A1 | PLANT-PROTEIN BASED TEXTURIZED OIL-IN-WATER EMULSIONS | Société des Produits Nestlé S.A. (CH) | 2020-10-21 | — | — | EP | disclosed |
| CN-111372474-A | Textured oil-in-water emulsions based on vegetable proteins | 雀巢产品有限公司 | 2020-07-03 | — | — | CN | disclosed |
| US-20200178563-A1 | A METHOD OF PRODUCING A FOOD OR BEVERAGE PRODUCT WITH FREE DIVALENT CATIONS DAIRY AND PLANT PROTEIN AGGREGATION | NESTEC S.A. (CH) | 2020-06-11 | — | — | US | disclosed |
| EP-3629749-A1 | A METHOD OF PRODUCING A FOOD OR BEVERAGE PRODUCT WITH FREE DIVALENT CATIONS DAIRY AND PLANT PROTEIN AGGREGATION | Société des Produits Nestlé S.A. (CH) | 2020-04-08 | — | — | EP | disclosed |
| CN-110799038-A | Method for producing food or beverage products with free divalent cation milk proteins and vegetable protein aggregates | 雀巢产品有限公司 | 2020-02-14 | — | — | CN | disclosed |
| CN-101460053-A | Methods and articles having a high antiviral and antibacterial efficacy | DIAL CORP (US) | 2009-06-17 | — | — | CN | disclosed |
| CN-101453890-A | Method of enhancing the control of viruses on skin | THR DIAL CORP (US) | 2009-06-10 | — | — | CN | disclosed |
| CN-101454012-A | Method for increased control of viruses on skin | THR DIAL CORP (US) | 2009-06-10 | — | — | CN | disclosed |
| CN-101453889-A | Composition and method for controlling the transmission of noroviruses | THR DIAL CORP (US) | 2009-06-10 | — | — | CN | disclosed |
| US-7445790-B2 | External preparations for skin | SHISEIDO COMPANY, LTD. (JP) | 2008-11-04 | — | — | US | disclosed |
| US-20050180931-A1 | External preparations for skin | SHISEIDO COMPANY, LTD. (JP) | 2005-08-18 | — | — | US | disclosed |
| EP-1550429-A1 | EXTERNAL PREPARATIONS FOR SKIN | SHISEIDO COMPANY, LTD. (JP) | 2005-07-06 | — | — | EP | disclosed |
| US-6039961-A | SALICYLIC ACID COMPOUND WITH HYDROPHOBIC HYDROCARBON, HALIDE OR ANHYDRIDE | COLETICA (FR) | 2000-03-21 | — | — | US | disclosed |
| US-5869069-A | APPLYING TO SKIN FOR KERATOLYTIC ACTIVITY | COLETICA (FR) | 1999-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050180931-A1 | External preparations for skin | CUTA, HRH1, CYP24A1 | MAPT 4238/4885DGKA 1292/4885LMNA 1962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.